Metropolis Healthcare sees strong Q4 performance driven by specialty and preventive testing push

Metropolis Healthcare reported a strong Q4 with significant growth in revenue, patient volumes, and profitability, driven by a shift towards specialized and preventive diagnostics. The company anticipates a steady medium-term growth of 14-15% CAGR, supported by successful integration of acquisitions and operational efficiencies.

Raccontata daeconomictimes.indiatimes.com